LG rolls out new monitors targeted at mammography reads

LG Business Solutions USA is rolling out new monitors targeted at radiologists who specialize in breast imaging, the company recently announced. 

The new 21HQ613D-B monitor, which is approved by the U.S. Food and Drug Administration, is intended to improve the process of reading breast MRIs, mammograms and DBT exams. It is a 21.3-inch 5-megapixel (MP) monitor that offers high-definition detail of radiologic images. 

The new product’s internal front sensor eliminates the need for an external calibration device. DICOM calibration can be completed through LG’s Calibration Studio medical software, which also provides quality assurance tests to help maintain quality control standards for medical monitors.  

Additionally, its Focus View Mode and Multi-Resolution Mode allow for quick screen adjustments for individual images, and there are numerous other features intended to improve radiologists’ reading experience. 

"LG's new 5MP diagnostic monitor is tailored for reviewing mammograms and breast tomosynthesis, providing a high-quality medical imaging display with both simple management and practical features for users,” Stephen K. Hu, LG Business Solutions USA’s head of medical displays, said in a release. “We’re dedicated to providing cutting-edge solutions for the medical sector with our display technologies, and the addition of the latest 5MP monitor underscores this commitment to innovation.” 

The importance of diagnostic monitors is often overlooked until lapses in quality are uncovered via inspection. In one such case in Arizona recently, a radiology group’s use of “less technologically sophisticated” monitors had a whistleblower questioning the legitimacy of their Medicare claims of services. 

The whistleblower claimed that the company wrongfully billed CMS for millions of dollars in image reads that they believed disqualified the group for Medicare reimbursement due to the subpar computer monitors used to view the studies. They described the monitors, which were not considered medical grade, as “less technologically sophisticated” and, therefore, less effective. 

That case has not yet been resolved. 

To learn more about the new monitor, click here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Trimed Popup
Trimed Popup